1991 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paolo Ghia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

Scarfò, L., Chatzikonstantinou, T., Rigolin, G. M., Quaresmini, G., Motta, M., Vitale, C., Garcia-Marco, J. A., Hernández-Rivas, J. Á., Mirás, F., Baile, M., Marquet, J., Niemann, C. U., Reda, G., Munir, T., Gimeno, E., Marchetti, M., Quaglia, F. M., Varettoni, M., Delgado, J., Iyengar, S. & 30 others, Janssens, A., Marasca, R., Ferrari, A., Cuéllar-García, C., Itchaki, G., Špaček, M., De Paoli, L., Laurenti, L., Levin, M. D., Lista, E., Mauro, F. R., Šimkovič, M., Van Der Spek, E., Vandenberghe, E., Trentin, L., Wasik-Szczepanek, E., Ruchlemer, R., Bron, D., De Paolis, M. R., Del Poeta, G., Farina, L., Foglietta, M., Gentile, M., Herishanu, Y., Herold, T., Jaksic, O., Kater, A. P., Rossi, D., Rossi, G. & Ghia, P., 2020, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Open Access
  • EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies

    Kiesewetter, B., Cherny, N. I., Boissel, N., Cerisoli, F., Dafni, U., De Vries, E. G. E., Ghia, P., Gökbuget, N., González-Calle, V., Huntly, B., Jäger, U., Latino, N. J., Douillard, J. Y., Malcovati, L., Mateos, M. V., Ossenkoppele, G. J., Porkka, K., Raderer, M., Ribera, J. M., Scarfò, L. & 3 others, Wester, R., Zygoura, P. & Sonneveld, P., Jan 20 2020, In : ESMO Open. 5, 1, e000611.

    Research output: Contribution to journalArticle

    Open Access
  • Cytogenetic complexity in chronic lymphocytic leukemia: Definitions, associations, and clinical impact

    on behalf of ERIC, the European Research Initiative on CLL, Jan 1 2019, In : Blood. 133, 11, p. 1205-1216 12 p.

    Research output: Contribution to journalArticle

    Open Access
  • Dichotomous Toll-like receptor responses in chronic lymphocytic leukemia patients under ibrutinib treatment

    Gounari, M., Ntoufa, S., Gerousi, M., Vilia, M. G., Moysiadis, T., Kotta, K., Papakonstantinou, N., Scarfò, L., Agathangelidis, A., Fonte, E., Ranghetti, P., Nenou, A., Xochelli, A., Coscia, M., Tedeschi, A., Stavroyianni, N., Muzio, M., Stamatopoulos, K. & Ghia, P., Apr 1 2019, In : Leukemia. 33, 4, p. 1030-1051 22 p.

    Research output: Contribution to journalLetter

    Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors

    Moysiadis, T., Baliakas, P., Rossi, D., Catherwood, M., Strefford, J. C., Delgado, J., Anagnostopoulos, A., Belessi, C., Stavroyianni, N., Pospisilova, S., Oscier, D., Gaidano, G., Campo, E., Rosenquist, R., Ghia, P. & Stamatopoulos, K., Jul 1 2019, In : Leukemia. 33, 7, p. 1801-1805 5 p.

    Research output: Contribution to journalLetter